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ABSTRACT 
The endocrinological, surgical, and histological findings of patients 
with ACTH-dependent Cushing’s disease were correlated with the 
pulsatile secretion pattern of ACTH and cortisol and the outcome after 
transsphenoidal pituitary surgery. A total of 28 patients were studied. 
The preoperative pulsatile secretion of ACTH and cortisol was assessed 
by sampling blood at 20-min intervals over 24 h. The pulsatile pattern 
of secretion was analyzed by the Cluster program. In 21 patients, an 
ACTH-secreting pituitary adenoma was identified and resected. Of 
these patients, 18 underwent clinical remission, and their cortisol 
secretion was suppressed to a normal level by low dose dexamethasone. 
Histological examinations in the patients with persistent disease re- 
vealed normal pituitary in 6 cases, nodular hyperplasia in 1, and ACTH- 
secreting pituitary adenoma in 3 cases. Analysis of the pulsatile pattern 
of ACTH and cortisol secretion did not reveal significant differences 
in timing, frequency, and/or amplitude of ACTH and cortisol pulses in 
normalized patients and those with persistent disease after surgery. It 
is concluded that analysis of the secretory pattern is not a suitable 
method for predicting the outcome of tra&phenoidal surgery in pa- 
tients with ACTH-dependent Cushing’s disease. (J Clin Endocrinol 
Metab 77: 720-124,1993) 
I T IS WELL established that functional endocrine testing of the hypothalamic-pituitary-adrenal axis allows confir- 
mation of the diagnosis of Cushing’s syndrome and differ- 
entiation between ACTH-dependent pituitary disease (Cush- 
ing’s disease) and hypercortisolism due to either ectopic 
ACTH-secreting neoplasia or cortisol-secreting adrenal tu- 
mors. Cushing’s disease, however, may be the result of an 
autonomous ACTH-secreting pituitary tumor or hypotha- 
lamic dysfunction. Clinically, it is important to be able to 
distinguish between these two etiologies, because patients 
with hypothalamic dysfunction do not benefit from trans- 
sphenoidal surgery, whereas ACTH-secreting pituitary tu- 
mors are clearly best treated by this approach. 
Preoperative differentiation between pituitary and hypo- 
thalamic disease cannot be achieved by standard biochemical 
investigations such as dexamethasone suppression tests (1) 
or stimulation tests with lysine vasopressin, insulin-induced 
hypoglycemia, or CRH (2). Neuroradiological examinations 
are also not particularly helpful in differentiating the entities, 
because in the majority of cases of Cushing’s disease, minute 
microadenomas do not produce major abnormalities in im- 
ages of the sella turcica region, and only about 50-60% of 
these small tumors within the gland are directly depicted by 
magnetic resonance scanning or computerized tomography. 
In an attempt to find biochemical differences between pa- 
tients with hypothalamic disease and patients with pituitary 
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tumors, van Cauter and Refetoff (3) analyzed literature data 
on the episodic secretion of cortisol in patients with Cushing’s 
disease and correlated them to the different etiologies of 
Cushing’s syndrome. Careful examination of the collected 
data suggested that a hypopulsatile secretion pattern of cor- 
tisol occurred in patients with autonomous ACTH-secreting 
pituitary tumors, whereas hyperpulsatile cortisol secretion 
was correlated with hypothalamic dysfunction. Based on 
their findings, the researchers proposed that differentiation 
of the two subgroups of patients with Cushing’s disease may 
be possible by assessing the pulsatile profile of cortisol and 
ACTH. If this hypothesis is correct, the clinical implications 
are obviously of high significance. The purpose of the present 
study was, therefore, to further examine pulsatile ACTH and 
cortisol secretion patterns in patients with Cushing’s disease 
and to correlate these to the surgical findings and the out- 
come of pituitary microsurgery. 
Subjects and Methods 
Between 1986 and 1989, 35 patients underwent transsphenoidal 
surgery as the primary treatment for Cushing’s disease in the Depart- 
ment of Neurosurgery, University of Erlangen-Niimberg. All had clinical 
evidence of hypercortisolism. Twenty-eight (23 females and 5 males) 
gave their informed consent to undergo a 24-h sampling of peripheral 
venous blood in 20-min intervals. All of the patients received routine 
preoperative endocrinological testing for the differential diagnosis of 
Cushing’s syndrome, as described previously (4). Included was overnight 
testing with low (2 mg) and high dose (8 and 16 mg, respectively) 
dexamethasone suppressibility and determination of cortisol and ACTH 
levels before and after iv CRH administration. Table 1 compiles the 
results of preoperative dynamic testing. Of 17 patients with negative 
imaging studies, 10 had simultaneous venous blood sampling from the 
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TABLE 1. Results of the preoperative dynamic endocrine tests 
Dexamethasone suppression CRH stimulation 
Patient Cortisol 
no. (nmol/L) Corns01 ACTH 
DST 2 mg DST 8 mg DST 16 mg (nmol/L) (pmol/L) 
1 6071212 I96 1158/1986 11.0/23.8 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
6321640 
2931154 
519/303 
248/91 
12691223 
827/372 
6321389 
1379/1020 
4131264 
4961248 
827 j579 
4961262 
6071259 
1765/1214 
1655/496 
607/358 
827180 
800/160 
1021/1076 
800/800 
1158/441 
3581248 
1214/1186 
9101524 
1076/882 
1108 
/1186 
j331 
1524 
1358 
139 
I259 
1138 
77212152 4618.5 
55211214 10.6113.4 
5241800 8.6/12.1 
4691579 16.9/39.2 
126911545 14.5163.8 
77211489 16.3162.1 
85511242 16.7/52.8 
1241/1655 3.719.0 
524/1379 8.1/81.5 
5241662 32.31108.8 
4131855 4.817.4 
5511938 3.3/12.1 
74411048 18.0174.0 
38611021 4.6118.0 
3311882 27.71111.0 
85511214 4.4135.5 
201412924 9.0/29.7 
359/1462 6.8/11.7 
82811766 6.6/46.0 
635/993 14.1/29.1 
74511573 13.2/154.1 
910/1379 20.2155.5 
6071882 22.0144.0 
303/910 23.8145.1 
118611379 32.1138.3 
690/1076 10.6141.2 
524/1020 8.8131.3 
petrosal sinuses performed to precisely localize the source of the ACTH 
excess and facilitate hemihypophysectomy in cases without a distinct 
microadenoma. 
Sampling technique 
A venous catheter was inserted in a forearm vein for serial blood 
sampling. A saline infusion was used to prevent obstruction of the 
catheter by clotting. Blood samples were then drawn in 20-min intervals 
for 24 h. The patient was allowed to sleep during the night and was not 
isolated from other patients, so that the normal daily rhythm was, as far 
as possible, not altered. The blood tubes contained Ca-EDTA and 
aprotinin. The samples were kept in an ice-water bath until centrifuga- 
tion, and the plasma was kept frozen at -80 C until assayed. 
Hormone determination 
Serum cortisol concentrations were assayed in duplicate using a 
commercially available RIA (Becton-Dickinson, Heidelberg, Germany). 
Normal basal values ranged from 275-579 nmol/L. Values below 28 
nmol/L were considered below the limit of assay detection. 
Plasma ACTH concentrations were determined in duplicate on silicic 
acid-extracted samples by a specific RIA with an N-terminal antibody. 
Svnthetic human ACTH-(l-21) ISvnacthen. Sandoz. Basel. Switzerland) 
ias used as standard. Normal ba’sal values ranged. from 4.4-l 1 pmol] 
L. Values below 0.9 pmol/L were considered to be below the assay 
detection limit (5). 
Transspherwidal microsurgery 
Transsphenoidal sella exploration and selective adenomectomy were 
performed as described previously (4). A standard sublabio-paraseptal- 
transsphenoidal approach to the sella turcica was used. In all cases, a 
careful microsurgical exploration of the intrasellar structures was per- 
formed. The pituitary body was serially sectioned in the coronal and 
sagittal planes. In 26 patients, tissue that was considered adenomatous 
was resected. In 2 cases, no microadenoma was detected, and a hemi- 
hypophysectomy was performed according to the ACTH gradient during 
inferior petrosal sinus sampling. The resected tissue was fixed with 
formalin, embedded in paraffin, and assessed by conventional and 
immunostaining for pituitary hormones by light microscopy. As soon as 
a suspected adenoma was resected, infusion therapy with hydrocortisone 
was commenced. The sella floor was closed by a fascia lata transplant. 
Postoperative testing 
All patients were followed up for at least 2 yr. Retesting was per- 
formed 7-10 days, 3 months, and 2 yr after surgery by determination 
of basal plasma ACTH and cortisol and cortisol suppressibility after 
overnight low dose (2 mg) dexamethasone testing. Patients were consid- 
ered to be in remission if clinical improvement and normal suppression 
of cortisol (to <55 nmol/L) after low dose dexamethasone were found 
(4). The status of disease at the latest follow-up visit was used to 
determine the persistence of hypercortisolism or (lasting) remission. 
Statistical analysis 
All data on pulsatile secretion of cortisol and ACTH obtained during 
the preoperative sampling were processed by the computerized pulse 
detection program Cluster (6, 7). t values to assess significant pulses 
were set at 2.0 and 2.0. A cluster of two peaks was used to define a 
peak and a nadir. 
Patient grouping 
Patients were grouped into those found to have a pituitary tumor 
and those without a tumor. Another grouping was performed on the 
criterion of whether a remission occurred after the operation. This 
classification, thus, resulted in four overlapping groups of patients. These 
were retrospectively examined in terms of pulsatile ACTH and cortisol 
secretion patterns. As there are no well defined limits for classifying a 
secretion pattern as hyper- or hypopulsatile, this distribution was per- 
formed in a simplified manner by orientation of the respective parameter 
to the mean value obtained for the whole collective. Values above this 
parameter were arbitrarily classified as hyperpulsatile; values below 
were classified as hypopulsatile. The significance of the individual 
parameters (Tables 2 and 3) was tested by comparing the mean values 
of the pulsatility parameters by Student’s t test. However, for the 
distribution of the hyper- and hypopulsatile secretion patterns to the 
various groups of patients (Tables 4 and 5), the x2 test was used. 
Results 
With two exceptions, preoperative dynamic endocrine test- 
ing of the patients revealed the classical findings of Cushing’s 
TABLE 2. Twenty-four-hour profiles of ACTH and cortisol 
secretion: patients with/without adenoma (Cluster analysis) 
No’ Of sig- Mean absolute 
Mean relative 
n&ant increase in 
peaks peak (pmol/L) significant peaks 
ACTH 
Patients with adenoma 5.95 + 5.24 19.4 f  17.0 1.98 f  1.24 
Patients without adenoma 4.71 f  3.95 17.3 + 13.5 1.93 f  1.81 
P NS NS NS 
Cortisol 
Patients with adenoma 3.95 f  2.36 725 f  427 1.66 f  0.75 
Patients without adenoma 4.00 f  3.46 910 rt 215 1.86 f  0.50 
P NS NS NS 
Values are the mean 31 SD. 
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TABLE 3. Twenty-four-hour profiles of ACTH and cortisol 
secretion: patients with/without remission (Cluster analysis) 
No. of sig- Me;$.lute M~mr&?~ 
nificant 
peaks (Pmom) 
significant 
peaks 
ACTH 
Patients with remission 6.56 + 5.44 18.9 f 18.3 2.00 f 1.34 
Patients without remission 4.00 f 3.43 18.8 f 11.8 1.92 & 1.48 
P NS NS NS 
Cortisol 
Patients with remission 3.67 f 2.38 720 + 463 1.66 -c 0.81 
Patients without remission 4.50 f 3.03 863 f 196 1.80 + 0.43 
P NS NS NS 
Values are the mean f SD. 
TABLE 4. Twenty-four-hour profiles of ACTH and cortisol 
secretion: hypopulsatile and hyperpulsatile secretion patterns in 
patient groups with/without adenoma 
Patients 
Adenoma No adenoma 
ACTH 
Hypopulsatile pattern 12 4 
Hyperpulsatile pattern 9 3 
Cortisol 
Hypopulsatile pattern 10 4 
Hyperpulsatile pattern 11 3 
TABLE 6. Twenty-four-hour profiles of ACTH and cortisol 
secretion: hypopulsatile and hyperpulsatile secretion patterns in 
patient groups with/without remission 
Patients 
Remission No remission 
ACTH 
Hypopulsatile pattern 11 5 
Hyperpulsatile pattern 7 5 
Cortisol 
Hypopulsatile pattern 8 5 
Hyperpulsatile pattern 10 5 
disease. One patient (no. 2) did not have an abolished diurnal 
cortisol rhythm, and in another (no. 26), 50% suppression of 
serum cortisol did not occur after overnight high dose dexa- 
methasone treatment. This latter patient had petrosal sinus 
sampling carried out to document that the pituitary gland 
was the source of the ACTH excess. 
In 18 of the patients (no. l-18), transsphenoidal microsur- 
gery achieved a lasting remission from Cushing’s disease. In 
this group of patients, selective adenomectomy was per- 
formed, and an ACTH-secreting microadenoma was immu- 
nohistochemically documented. Among the 10 patients with 
persistent disease after surgery (no. 19-28), ACTH-secreting 
microadenomas were immunohistochemically documented 
in only 3 cases (nos. 22, 25, and 27). In one of these cases, 
the tumor was found to be invasive into the cavernous sinus 
(no. 27) and, thus, surgically uncurable for technical reasons. 
In 1 case (no. 28), the resected specimen histologically rep- 
resented nodular hyperplasia of ACTH-secreting cells. No 
adenoma was found during pituitary microsurgery in 6 cases, 
and biopsies of either the pituitary gland (in 3 cases) or the 
hemihypophysectomy specimen (in 3 cases) did not provide 
evidence of adenomatous tissue. 
In comparison of the groups of patients with remission 
and persistence of the disease and in the groups with and 
without a pituitary adenoma found during transsphenoidal 
sella exploration, there was no significant difference in any 
one of the parameters, in contradiction to the hypothesis of 
van Cauter and Refetoff (3). The mean values are reported 
in detail in Tables 2 and 3. However, the most striking finding 
was that both hypopulsatile and hyperpulsatile secretion 
patterns were encountered in patients with surgically and 
histologically verified ACTH-secreting pituitary adenomas, 
the resection of which was followed by a sustained remission 
of the disease. 
Comparison of the patient groups with respect to a hyper- 
pulsatile or hypopulsatile secretion pattern of both hor- 
mones, ACTH and cortisol, did not reveal obvious differences 
between those subjects who were found to harbor an ade- 
noma and those in whom no adenoma could be detected 
(Table 4). In addition, the distinction between hyper- and 
hypopulsatile rhythms failed to differentiate those who post- 
operatively remitted from the disease and those who were 
found to suffer from persistent hypercortisolism after surgery 
(Table 5). 
Discussion 
The results of this study demonstrate that analysis of the 
pulsatile secretion of ACTH and cortisol has little prognostic 
value in preoperative assessment of patients with Cushing’s 
disease. Our study shows that daily ACTH and cortisol 
secretion profiles do not allow the prediction of postoperative 
outcome or of whether a tumor will be found during surgery. 
Our findings are, therefore, in marked contradiction to the 
hypothesis of van Cauter and Refetoff (3), who suggested 
that Cushing’s disease due to an autonomous ACTH-secret- 
ing pituitary tumor should exclusively be associated with 
hypopulsatile secretion patterns. This hypothesis was for- 
mulated from the analysis of patients studied in multiple 
centers and using inhomogenous sampling intervals. The 
present findings of both hypo- and hyperpulsatile patterns 
of ACTH and cortisol secretion in patients who were docu- 
mented to have ACTH-secreting pituitary adenomas and 
Cushing’s disesase by itself refute the intriguing hypothesis 
of van Cauter and Refetoff. Furthermore, when Liu et al. (8) 
compared daily profiles of ACTH and cortisol secretion, they 
found that a hyperpulsatile secretion pattern of ACTH does 
not necessarily lead to a hyperpulsatile cortisol secretion 
pattern. Similar findings were described by Gallagher et al. 
(9), Krieger and Allen (lo), and Schiirmeier (11). The present 
study further shows that this dissociation is frequently found, 
as documented by Tables 4 and 5, which compile data on 
the hyper- and hypopulsatile secretion patterns of ACTH 
and cortisol in relation to whether an adenoma was found 
and whether the patient remitted. Liu et al. (8) suggest a 
variable sensitivity of the adrenal cortex to ACTH pulses as 
an explanation for this dissociation. For individual cases, 
therefore, one cannot deduce pituitary ACTH pulsatility on 
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the basis of pulsatile cortisol secretion. Correspondingly, the 
daily profiles of cortisol secretion assessed by measuring 
cortisol in the serum or plasma will not allow reliable conclu- 
sions on the intrinsic secretion rhythm of the pituitary gland 
or the pathophysiology of Cushing’s disease in the individual 
patient. 
Furthermore, Gambacciani et al. (12) showed that human 
fetal and adult pituitary cells in vitro did not continuously 
secrete a constant amount of ACTH, but developed an organ- 
specific rhythm of ACTH secretion. Because isolated culture 
was used, these cells were deprived of hypothalamic stimu- 
lation and feedback mechanisms. It seems that the pituitary 
corticotrophs harbor an intrinsic CRH-independent secretion 
rhythm. Similar findings in in vitro cell culture experiments 
were described by other groups for the secretion of PRL (13), 
GH (14), and LH (15). This autonomous pulsatile secretion 
of isolated pituitary cells as a whole is one further argument 
that disproves the hypothesis of van Cauter and Refetoff (3). 
A differentiation between this intrinsic pulsatility rhythm 
and the rhythm of an underlying hypothalamic pulsatility 
generator on the basis of variation in plasma ACTH and 
cortisol rhythms is difficult. Thus, the original source of the 
pulse rhythm is impossible to trace with the currently avail- 
able analytical methods. 
There are, however, many further problems associated 
with a study of this episodic character. A large variety of 
different influences could play a role in generating a hyper- 
pulsatile or hypopulsatile secretion rhythm. Krieger (16) 
postulated organ-specific intrinsic day rhythms in the hy- 
pothalamus, pituitary gland, and adrenal cortex. Clinical 
observations in patients with Cushing’s disease suggest that 
the sensitivity of the feedback system may exhibit cyclic 
changes (17). Low frequency secretion patterns with cycles 
lasting for weeks (18) and even intermittent short phases of 
remission (19) may occur. 
Other biochemical assessments have proven to be equally 
disappointing in helping to differentiate the different path- 
ophysiologies of Cushing’s disease (20, 21). None of the 
routinely used preoperative tests appear to be of diagnostic 
value, and the responses of cortisol and ACTH to CRH do 
not significantly differ in patients with hypothalamic or 
pituitary Cushing’s disease (22). CRH measurements per- 
formed during venous blood samling from the petrosal sinus 
also are of limited value (23). 
One problem with the present study was that the amount 
of blood minimally required to determine ACTH by a radio- 
immunological technique after an extraction procedure lim- 
ited more frequent sampling, i.e. in shorter intervals. Appli- 
cation of a recently developed immunoradiometric assay 
technique (24) for measuring ACTH would offer some ad- 
vantage in this respect. 
Although the development of a method to differentiate 
between hypothalamic and pituitary Cushing’s disease re- 
mains desirable, it is worth noting that pituitary surgery in 
experienced centers very often leads to clinical remission. 
Thus, techniques for determining the etiology of Cushing’s 
disease must be carefully evaluated in terms of the extra risks 
in using an additional invasive procedure in relation to the 
success rate and side-effects of an onerative sella exuloration 
(4, 25). 
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